In HCC cells, down-regulation of these isoforms could lead to delayed PDGFR degradation that could give rise to a sustained signalling of PDGF and downstream pathways, resulting in enhanced proliferation. This evidence concerns the gene PDGFRB and hepatocellular carcinoma.